Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BOLD

Boundless Bio (BOLD)

Boundless Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BOLD
DateTimeSourceHeadlineSymbolCompany
04/11/20248:00AMBusiness WireBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene AmplificationsNASDAQ:BOLDBoundless Bio Inc
04/08/20248:00AMBusiness WireBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024NASDAQ:BOLDBoundless Bio Inc
02/14/20205:23PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/14/20204:35PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/14/20204:15PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
02/11/20204:41PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
02/05/202011:27AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
01/27/20209:38AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:BOLDBoundless Bio Inc
01/21/20206:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
01/21/20206:00AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BOLDBoundless Bio Inc
12/03/20197:13PMPR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Audentes Therapeutics, Inc.NASDAQ:BOLDBoundless Bio Inc
12/02/20196:01PMBusiness WireAstellas Enters into Definitive Agreement to Acquire Audentes TherapeuticsNASDAQ:BOLDBoundless Bio Inc
11/26/20194:01PMBusiness WireAudentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
11/12/20195:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
11/12/201912:13PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BOLDBoundless Bio Inc
11/07/20195:18PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BOLDBoundless Bio Inc
11/07/20194:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
11/07/20194:01PMBusiness WireAudentes Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate UpdateNASDAQ:BOLDBoundless Bio Inc
10/31/20197:00AMBusiness WireAudentes Therapeutics to Release Third Quarter 2019 Financial Results and Provide Corporate Update on Thursday, November 7, 2...NASDAQ:BOLDBoundless Bio Inc
10/09/20196:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BOLDBoundless Bio Inc
10/05/20197:01AMBusiness WireAudentes Therapeutics Presents New Positive Data from ASPIRO, the Clinical Trial Evaluating AT132 in Patients with X-Linked M...NASDAQ:BOLDBoundless Bio Inc
10/04/20196:00PMBusiness WireAudentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
10/01/20198:00AMBusiness WireAudentes Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BOLDBoundless Bio Inc
09/30/20198:00AMBusiness WireAudentes Announces Upcoming Presentations at the 24th International Annual Congress of the World Muscle Society, Including Ne...NASDAQ:BOLDBoundless Bio Inc
09/25/20196:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
09/16/20194:18PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BOLDBoundless Bio Inc
09/09/20194:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
09/09/20194:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
09/09/20194:05PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BOLDBoundless Bio Inc
09/06/20196:00PMBusiness WireAudentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BOLDBoundless Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BOLD